Prosecution Insights
Prosecution Insights
Technology areas: Chemistry & Materials • Transportation, E-Commerce & Mechanical Systems
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Travera, Inc. is currently managing 3 pending office actions in the Chemistry & Materials technology area. The portfolio's active matters are spread across 3 distinct art units, with each case assigned to a distinct examiner. This distribution ensures that no single examiner has a concentrated influence over the company's current prosecution efforts.
HYUN, PAUL SANG HWA is the busiest examiner with 1 pending case, matching the workload of the other examiners. Because the pending office actions are each in a different art unit, the company must address the specific standards of the units. This direct ratio of cases to examiners simplifies individual tracking. The 1 pending case per examiner defines the current landscape.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (33%) |
| §101 + other | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HYUN, PAUL SANG HWA | 1 | 69.8% | +36.5% |
| JARRETT, LORE RAMILLANO | 1 | 68.5% | +25.1% |
| COLEMAN, CHARLES P. | 1 | 16.0% | +19.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17732769 | CALIBRATION OF A FUNCTIONAL BIOMARKER INSTRUMENT | JARRETT, LORE RAMILLANO | 114d overdue |
| 17901190 | CELLULAR MEASUREMENT CALIBRATION AND CLASSIFICATION | HYUN, PAUL SANG HWA | 8d |
| 16739814 | MACHINE LEARNING IN FUNCTIONAL CANCER ASSAYS | COLEMAN, CHARLES P. | 15d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17732769 | CALIBRATION OF A FUNCTIONAL BIOMARKER INSTRUMENT | JARRETT, LORE RAMILLANO | 114d overdue |
| 17901190 | CELLULAR MEASUREMENT CALIBRATION AND CLASSIFICATION | HYUN, PAUL SANG HWA | 8d |
| 16739814 | MACHINE LEARNING IN FUNCTIONAL CANCER ASSAYS | COLEMAN, CHARLES P. | 15d |
| Art Unit | Apps |
|---|---|
| 1796 | 1 |
| 1797 | 1 |
| 3683 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17901190 | CELLULAR MEASUREMENT CALIBRATION AND CLASSIFICATION | HYUN, PAUL SANG HWA | 1796 | §103§112 | Final Rejection | 8d | Pending | Sep 01, 2022 |
| 17732769 | CALIBRATION OF A FUNCTIONAL BIOMARKER INSTRUMENT | JARRETT, LORE RAMILLANO | 1797 | §101§103§112DP | Non-Final OA | 114d overdue | Pending | Apr 29, 2022 |
| 16739814 | MACHINE LEARNING IN FUNCTIONAL CANCER ASSAYS | COLEMAN, CHARLES P. | 3683 | §101 | Final Rejection | 15d | Pending | Jan 10, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial